(NASDAQ:AMLX) shares are up 20% again in pre-market trading on news of the FDA extending the review timeline of it’s new drug application.  Shares are trading at $11.94 a share on more than 7,000 trades.

New PDUFA goal date scheduled for September 29, 2022 to allow time to review additional data

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.